ACCORD HEALTHCARE POLSKA SP. Z.O.O. — Etoposide Importer Profile
Pharmaceutical Importer · #14 buyer for Etoposide · $319.5K import value · 39 shipments · POLAND · DGFT Verified
ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the #14 importer of Etoposide from India with $319.5K in import value and 39 verified shipments. ACCORD HEALTHCARE POLSKA SP. Z.O.O. holds a 1.2% market share in Etoposide imports based in POLAND. The company sources from 1 verified supplier across 21 formulations shipped to 1 country. Overall, ACCORD HEALTHCARE POLSKA SP. Z.O.O. imports 8 pharmaceutical products worth $5.8M across 2 therapeutic categories.
ACCORD HEALTHCARE POLSKA SP. Z.O.O. — Etoposide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Etoposide to ACCORD HEALTHCARE POLSKA SP. Z.O.O.?
Verified from 39 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $319.5K | 39 | 100.0% |
ACCORD HEALTHCARE POLSKA SP. Z.O.O. sources Etoposide from 1 verified Indian supplier based on 39 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Compare to Nearest Etoposide Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | ROPSOHN THERAPEUTICS SAS | COLOMBIA | $150.0K | 3 | $50.0K |
| 13 | FRESENIUS KABI TAIWAN LTD | TAIWAN | $135.5K | 4 | $33.9K |
| 14 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. ★ | POLAND | $134.6K | 20 | $6.7K |
| 8 | CSP MYLAN IRELAND LIMITED | FRANCE | $100.0K | 2 | $50.0K |
ACCORD HEALTHCARE POLSKA SP. Z.O.O. ranks #14 among 598 Etoposide importers from India. Average shipment value of $6.7K compared to the market average of $7.8K. The closest competitors by value are ROPSOHN THERAPEUTICS SAS and FRESENIUS KABI TAIWAN LTD.
Where Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Import Etoposide To?
Destination countries from 39 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| POLAND | $319.5K | 39 | 100.0% |
ACCORD HEALTHCARE POLSKA SP. Z.O.O. imports Etoposide to 1 country. The primary destination is POLAND receiving 100.0% of shipments worth $319.5K.
What Etoposide Formulations Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/M | $73.2K | 12 |
| PHA.DRU & MEDI, ETOPOSIDE INJ,20MG/ML,10ML(ACCORD-POLAND Each ml contains : Etoposide Ph.Eur. .....20 mg Benz | $30.1K | 2 |
| PHARMA DRUGS & MEDI ETOPOSIDE INJ USP,20 | $30.0K | 3 |
| PHARMA DRUG&MED:ETOPOSIDE INJ,20MG/ML,10 | $27.0K | 3 |
| PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML12.5ML(ACO-CZ)EACH ML CONT:ETOPOSIDE PH.EUR 20MG BENZYL ALCOHOL PH.E(ASPERINV) | $22.8K | 1 |
| PHARMA DRUGS & MEDI ETOPOSIDE INJ20MG/M | $15.6K | 1 |
| PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML5ML(ACCORD-POLA)EACH ML CONT:ETOPOSIDE PH.EUR. 20MG BENZYL ALCOHOL PH(ASPERINV) | $15.0K | 1 |
| PHA.DRU & MEDI, ETOPOSIDE INJ,20MG/ML,20ML(ACCORD-POLAND Each ml contains :Etoposide Ph.Eur.20 mg Benzyl alcohol Ph.Eur. | $14.1K | 1 |
| PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML5ML(ACCORD-BULGA)EACH ML CONT:ETOPOSIDEPH.EUR. 20MG BENZYL ALCOHOL PH(ASPERINV) | $10.5K | 1 |
| PHARMA DRUGS & MEDI ETOPOSIDE INJ USP,20MG/ML,5ML(ACCO-BULGA AS PER INVOICE | $10.4K | 1 |
ACCORD HEALTHCARE POLSKA SP. Z.O.O. imports 21 distinct Etoposide formulations from India. The top formulation is PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/M with 12 shipments worth $73.2K.
Who Are the Top Buyers of Etoposide from India and How Much Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Import?
India exported $4.7M worth of Etoposide through 2,129 shipments from 237 suppliers to 122 countries, serving 598 buyers globally. ACCORD HEALTHCARE POLSKA SP. Z.O.O. imports $319.5K of this total, accounting for 1.2% of India's Etoposide exports with 39 shipments from POLAND. This is verified from 39 customs shipment records covering 21 distinct formulations.
What Is the Average Order Value for ACCORD HEALTHCARE POLSKA SP. Z.O.O.'s Etoposide Imports?
ACCORD HEALTHCARE POLSKA SP. Z.O.O.'s average Etoposide order value is $8.2K per consignment, based on 39 shipments totaling $319.5K. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is based in POLAND and ranks #14 among all Etoposide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Etoposide to ACCORD HEALTHCARE POLSKA SP. Z.O.O.?
ACCORD HEALTHCARE POLSKA SP. Z.O.O. sources Etoposide from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($319.5K, 100.0%). This is based on 39 customs records.
How Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Compare to Other Etoposide Importers?
ACCORD HEALTHCARE POLSKA SP. Z.O.O. ranks #14 among 598 Etoposide importers from India with a 1.2% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES,LLC ($1.5M), FRESENIUS KABI DEUTSCHLAND GMBH ($475.0K), AMERISOURCE HEALTH SERVICES ($350.0K). ACCORD HEALTHCARE POLSKA SP. Z.O.O. processed 39 shipments from POLAND.
What Other Oncology Products Does ACCORD HEALTHCARE POLSKA SP. Z.O.O. Import?
ACCORD HEALTHCARE POLSKA SP. Z.O.O. also imports these oncology products. Each links to the detailed product page.
About ACCORD HEALTHCARE POLSKA SP. Z.O.O.
ACCORD HEALTHCARE POLSKA SP. Z.O.O. imports 8 products worth $5.8M. Beyond Etoposide, top products include Irinotecan, Topotecan, Fludarabine, Vinorelbine, Fulvestrant. View the complete ACCORD HEALTHCARE POLSKA SP. Z.O.O. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Etoposide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Etoposide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ACCORD HEALTHCARE POLSKA SP. Z.O.O. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ACCORD HEALTHCARE POLSKA SP. Z.O.O.'s capped import value divided by total capped export value for Etoposide across all Indian exporters.
- 5.Verified Records: This page is backed by 39 individual customs records matching ACCORD HEALTHCARE POLSKA SP. Z.O.O. importing Etoposide, covering 21 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 598+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Etoposide Import Data for ACCORD HEALTHCARE POLSKA SP. Z.O.O.
Access order-level details, pricing data, supplier connections, and competitive analysis for ACCORD HEALTHCARE POLSKA SP. Z.O.O.'s Etoposide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ACCORD HEALTHCARE POLSKA SP. Z.O.O.
Full Company Profile →
8 products · $5.8M total trade · 2 categories
ACCORD HEALTHCARE POLSKA SP. Z.O.O. × Etoposide
Verified from customs records
Company Overview
Top Products by ACCORD HEALTHCARE POLSKA SP. Z.O.O.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ACCORD HEALTHCARE POLSKA SP. Z.O.O..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etoposide. For current order-level data, contact TransData Nexus.